Medy-Tox Inc (086900) — Cash Flow Quality Index
Medy-Tox Inc (086900) has a Cash Flow Quality Index of 2.56x as of September 2025. Operating cash flow of ₩19.03 Billion exceeds net income of ₩7.43 Billion, indicating high earnings quality where cash backs reported profits. Explore Medy-Tox Inc long-term investment allocation to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Medy-Tox Inc Cash Flow Quality Index (2013–2024)
Historical Cash Flow Quality Index for Medy-Tox Inc across 11 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check tangible net worth ratio of Medy-Tox Inc to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Medy-Tox Inc (2013–2024)
Year-by-year earnings quality comparison for Medy-Tox Inc. For live market cap and the full company financial profile, see 086900 market cap.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 2.30x | ₩36.89 Billion | ₩16.07 Billion | ▲ +63.7% |
| 2023 | 1.40x | ₩13.52 Billion | ₩9.64 Billion | ▲ +101.1% |
| 2022 | 0.70x | ₩26.20 Billion | ₩37.57 Billion | ▲ +235.9% |
| 2021 | 0.21x | ₩19.97 Billion | ₩96.16 Billion | ▼ -83.9% |
| 2019 | 1.29x | ₩33.70 Billion | ₩26.21 Billion | ▲ +63.4% |
| 2018 | 0.79x | ₩55.07 Billion | ₩69.96 Billion | ▼ -2.4% |
| 2017 | 0.81x | ₩56.55 Billion | ₩70.11 Billion | ▼ -11.7% |
| 2016 | 0.91x | ₩54.10 Billion | ₩59.23 Billion | ▲ +72.7% |
| 2015 | 0.53x | ₩22.37 Billion | ₩42.29 Billion | ▼ -78.1% |
| 2014 | 2.42x | ₩105.38 Billion | ₩43.63 Billion | ▲ +108.2% |
| 2013 | 1.16x | ₩16.60 Billion | ₩14.30 Billion | — |